SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001524679-15-000002
Filing Date
2015-06-24
Accepted
2015-06-24 18:20:19
Documents
1
Period of Report
2015-05-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2176
  Complete submission text file 0001524679-15-000002.txt   3829
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 244 5TH AVENUE SUITE 1727 NEW YORK NY 10001
Business Address 244 5TH AVENUE SUITE 1727 NEW YORK NY 10001 5407600535
Immune Response BioPharma, Inc. (Reporting) CIK: 0001524679 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-19756 | Film No.: 15950192